Search Results - "Wulffraat, Nico M"

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus by Martini, Alberto, Ravelli, Angelo, Avcin, Tadej, Beresford, Michael W, Burgos-Vargas, Ruben, Cuttica, Ruben, Ilowite, Norman T, Khubchandani, Raju, Laxer, Ronald M, Lovell, Daniel J, Petty, Ross E, Wallace, Carol A, Wulffraat, Nico M, Pistorio, Angela, Ruperto, Nicolino

“…To revise the current juvenile idiopathic arthritis (JIA) International League of Associations for Rheumatology (ILAR) classification criteria with an…”
Get full text

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study by ter Haar, Nienke M., Dijkhuizen, E. H. Pieter, Swart, Joost F., Royen‐Kerkhof, Annet, el Idrissi, Ayman, Leek, Arjen P., Jager, Wilco, Groot, Mark C. H., Haitjema, Saskia, Holzinger, Dirk, Foell, Dirk, Loosdregt, Jorg, Wulffraat, Nico M., Roock, Sytze, Vastert, Sebastiaan J.

“…Objective Systemic juvenile idiopathic arthritis (JIA) is a multifactorial autoinflammatory disease with a historically poor prognosis. With current treatment…”
Get full text

Recommendations for the management of autoinflammatory diseases by ter Haar, Nienke M, Oswald, Marlen, Jeyaratnam, Jerold, Anton, Jordi, Barron, Karyl S, Brogan, Paul A, Cantarini, Luca, Galeotti, Caroline, Grateau, Gilles, Hentgen, Veronique, Hofer, Michael, Kallinich, Tilmann, Kone-Paut, Isabelle, Lachmann, Helen J, Ozdogan, Huri, Ozen, Seza, Russo, Ricardo, Simon, Anna, Uziel, Yosef, Wouters, Carine, Feldman, Brian M, Vastert, Sebastiaan J, Wulffraat, Nico M, Benseler, Susanne M, Frenkel, Joost, Gattorno, Marco, Kuemmerle-Deschner, Jasmin B

“…: Autoinflammatory diseases are characterised by fever and systemic inflammation, with potentially serious complications. Owing to the rarity of these…”
Get more information

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative by Groot, Noortje, de Graeff, Nienke, Marks, Stephen D, Brogan, Paul, Avcin, Tadej, Bader-Meunier, Brigitte, Dolezalova, Pavla, Feldman, Brian M, Kone-Paut, Isabelle, Lahdenne, Pekka, McCann, Liza, Özen, Seza, Pilkington, Clarissa A, Ravelli, Angelo, Royen-Kerkhof, Annet van, Uziel, Yosef, Vastert, Bas J, Wulffraat, Nico M, Beresford, Michael W, Kamphuis, Sylvia

“…Lupus nephritis (LN) occurs in 50%-60% of patients with childhood-onset systemic lupus erythematosus (cSLE), leading to significant morbidity. Timely…”
Get more information

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases by Snowden, John A., Badoglio, Manuela, Labopin, Myriam, Giebel, Sebastian, McGrath, Eoin, Marjanovic, Zora, Burman, Joachim, Moore, John, Rovira, Montserrat, Wulffraat, Nico M., Kazmi, Majid, Greco, Raffaella, Snarski, Emilian, Kozak, Tomas, Kirgizov, Kirill, Alexander, Tobias, Bader, Peter, Saccardi, Riccardo, Farge, Dominique

“…Hematopoietic stem cell transplantation (HSCT) has evolved for >20 years as a specific treatment of patients with autoimmune disease (AD). Using European…”
Get full text

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases by Furer, Victoria, Rondaan, Christien, Agmon-Levin, Nancy, van Assen, Sander, Bijl, Marc, Kapetanovic, Meliha Crnkic, de Thurah, Annette, Mueller-Ladner, Ulf, Paran, Daphna, Schreiber, Karen, Warnatz, Klaus, Wulffraat, Nico M, Elkayam, Ori

“…In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases…”
Get full text

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better? by Gennery, Andrew R., MD, Slatter, Mary A., MD, Grandin, Laure, MSc, Taupin, Pierre, MD, Cant, Andrew J., FRCP, Veys, Paul, FRCP, Amrolia, Persis J., FRCP, Gaspar, H. Bobby, PhD, Davies, E. Graham, FRCPCH, Friedrich, Wilhelm, PhD, Hoenig, Manfred, MD, Notarangelo, Luigi D., MD, Mazzolari, Evelina, MD, Porta, Fulvio, MD, Bredius, Robbert G.M., PhD, Lankester, Arjen C., PhD, Wulffraat, Nico M., PhD, Seger, Reinhard, MD, Güngör, Tayfun, MD, Fasth, Anders, PhD, Sedlacek, Petr, PhD, Neven, Benedicte, MD, Blanche, Stephane, MD, Fischer, Alain, PhD, Cavazzana-Calvo, Marina, PhD, Landais, Paul, PhD

“…Background Hematopoietic stem cell transplantation remains the only treatment for most patients with severe combined immunodeficiencies (SCIDs) or other…”
Get full text

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis by de Rotte, Maurits C F J, Pluijm, Saskia M F, de Jong, Pascal H P, Bulatović Ćalasan, Maja, Wulffraat, Nico M, Weel, Angelique E A M, Lindemans, Jan, Hazes, J M W, de Jonge, Robert

“…The objective was to predict insufficient response to 3 months methotrexate (MTX) in DMARD naïve rheumatoid arthritis patients. A Multivariable logistic…”
Get full text

Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children by de Sonnaville, Willemijn F C, Steenks, Michel H, Zuithoff, Nicolaas P A, Wulffraat, Nico M, Rosenberg, Antoine J W P, Speksnijder, Caroline M

“…In children with juvenile idiopathic arthritis (JIA) the temporomandibular joint (TMJ) can be involved. As a consequence, the oral function can be impaired due…”
Get full text

Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use by van Straalen, Joeri W, Krol, Roline M, Giancane, Gabriella, Panaviene, Violeta, Ailioaie, Laura Marinela, Doležalová, Pavla, Cattalini, Marco, Susic, Gordana, Sztajnbok, Flavio R, Maritsi, Despoina, Constantin, Tamas, Sawhney, Sujata, Rygg, Marite, Oliveira, Sheila Knupp, Nordal, Ellen Berit, Saad-Magalhães, Claudia, Rubio-Perez, Nadina, Jelusic, Marija, de Roock, Sytze, Wulffraat, Nico M, Ruperto, Nicolino, Swart, Joost F

“…Abstract Objective To describe risk factors for IBD development in a cohort of children with JIA. Methods JIA patients who developed IBD were identified from…”
Get full text

Genomic Health Literacy Interventions in Pediatrics: Scoping Review by Gupta, Aarushi, Cafazzo, Joseph A, IJzerman, Maarten J, Swart, Joost F, Vastert, Sebastiaan, Wulffraat, Nico M, Benseler, Susanne, Marshall, Deborah, Yeung, Rae, Twilt, Marinka

“…The emergence of genetic and genomic sequencing approaches for pediatric patients has raised questions about the genomic health literacy levels, attitudes…”
Get full text

Explaining placebo effects in an online survey study: Does 'Pavlov' ring a bell? by Smits, Rosanne M, Veldhuijzen, Dieuwke S, Olde Hartman, Tim, Peerdeman, Kaya J, Van Vliet, Liesbeth M, Van Middendorp, Henriët, Rippe, Ralph C A, Wulffraat, Nico M, Evers, Andrea W M

“…Despite the increasing knowledge about placebo effects and their beneficial impact on treatment outcomes, strategies that explicitly employ these mechanisms…”
Get full text

The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis by Hamad Saied, Mohamad, van der Griend, Laura, van Straalen, Joeri W, Wulffraat, Nico M, Vastert, Sebastiaan, Jansen, Marc H A

“…To review whether the current COVID-19 vaccines can prevent the occurrence of multisystem inflammatory syndrome in children (MIS-C) and adolescents. A…”
Get full text

Identifying disrupted biological factors and patient-tailored interventions for chronic fatigue in adolescents and young adults with Q-Fever Fatigue Syndrome, Chronic Fatigue Syndrome and Juvenile Idiopathic Arthritis (QFS-study): study protocol for a randomized controlled trial with single-subject experimental case series design by Vroegindeweij, Anouk, Swart, Joost F, Houtveen, Jan, Eijkelkamp, Niels, van de Putte, Elise M, Wulffraat, Nico M, Nijhof, Sanne L

“…Abstract Background Chronic fatigue with a debilitating effect on daily life is a frequently reported symptom among adolescents and young adults with a history…”
Get full text

Time to share by Wulffraat, Nico M, Vastert, Bas

“…In the following a brief commentary is given on a new European project that aims to provide the European countries with recommendations for the care of…”
Get full text

Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals? by Schoemaker, Casper G, Swart, Joost F, Wulffraat, Nico M

“…In 2018, an international Task Force formulated recommendations for treating Juvenile Idiopathic Arthritis (JIA) to target. The Task Force has not yet resolved…”
Get full text

Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries survey by Papa, Riccardo, Cant, Andrew, Klein, Christoph, Little, Mark A, Wulffraat, Nico M, Gattorno, Marco, Ruperto, Nicolino

“…The Rare Immunodeficiency, AutoInflammatory and AutoImmune Disease (RITA) network is a European Research Network (ERN) that brings together the leading centres…”
Get full text

Feasibility of quantitative sensory testing in juvenile idiopathic arthritis by Mensink, Maarten O, Eijkelkamp, Niels, Veldhuijzen, Dieuwke S, Wulffraat, Nico M

“…Abstract Objective Juvenile Idiopathic Arthritis (JIA) is a childhood-rheumatic disease with pain as a major early complaint, and in 10–17% pain remains a…”
Get full text

Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown by Kalinina Ayuso, Viera, PhD, MD, Makhotkina, Nathalia, MD, van Tent-Hoeve, Maretta, MD, de Groot-Mijnes, Jolanda D.F., PhD, Wulffraat, Nico M., PhD, MD, Rothova, Aniki, PhD, MD, de Boer, Joke H., PhD, MD

“…Abstract Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease and the most prevalent systemic disorder in children with uveitis…”
Get full text

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study by Grazziotin, Luiza R, Currie, Gillian, Twilt, Marinka, Ijzerman, Maarten J, Kip, Michelle M A, Koffijberg, Hendrik, Benseler, Susanne M, Swart, Joost F, Vastert, Sebastiaan J, Wulffraat, Nico M, Yeung, Rae S M, Marshall, Deborah A

“…Pharmacological treatment is a cornerstone of care for children with juvenile idiopathic arthritis (JIA). The objective of this study is to evaluate…”
Get full text